{"id":"W4393238711","doi":"10.1016/s2352-3026(24)00045-0","title":"Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1–2 trial","year":2024,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Manitoba","funders":"Janssen Research and Development; National Institutes of Health; Incyte; bluebird bio; National Center for Advancing Translational Sciences; Health Resources and Services Administration; Agios Pharmaceuticals; Chiesi Farmaceutici; Bayer Corporation; CSL Behring; Novo Nordisk; Teva Pharmaceutical Industries; United Therapeutics Corporation; Celgene; Bayer HealthCare; Sanofi; Alexion Pharmaceuticals; Penn State College of Medicine; University of Pittsburgh; National Heart, Lung, and Blood Institute; Vifor Pharma; Pfizer","keywords":"Medicine; Riociguat; Placebo; Proteinuria; Internal medicine; Sickle cell anemia; Disease; Clinical trial; Anemia; Gastroenterology; Pulmonary hypertension; Kidney; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003024393,0.000246792,0.001309964,0.0001187552,0.0000923348,0.00004403818,0.0001001095,0.00016612,0.00009393581],"category_scores_gemma":[0.00007653811,0.0001126589,0.0000737878,0.0002118296,0.0001927415,0.00006449755,0.00004925485,0.000393383,0.00003303169],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002690834,"about_ca_system_score_gemma":0.0001682491,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003905859,"about_ca_topic_score_gemma":0.0000359657,"domain_scores_codex":[0.9984524,0.0001596009,0.0004114629,0.0003710227,0.0002059431,0.0003995435],"domain_scores_gemma":[0.9990836,0.0002556849,0.00009484888,0.0003520157,0.00005210865,0.0001617133],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9941584,0.001186407,0.0003346955,0.0004570803,0.0001403702,0.001340063,0.0004631936,0.000008195557,0.00004982822,0.0001090191,0.001052454,0.0007002982],"study_design_scores_gemma":[0.9933881,0.002698681,0.00005943829,0.000384151,0.0005326305,0.0001727989,0.0001587423,0.0009205485,0.00004577127,0.00009758311,0.001372149,0.0001693693],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9845622,0.002167151,0.00001947883,0.00412673,0.0003081419,0.008166084,0.000009413267,0.00009128915,0.0005494787],"genre_scores_gemma":[0.9977561,0.0002140462,0.00003621761,0.0004944533,0.000149926,0.0006652507,0.00003431579,0.0000376407,0.000612013],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0131939,"threshold_uncertainty_score":0.4594097,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02517269675344845,"score_gpt":0.2861932875726454,"score_spread":0.2610205908191969,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}